Achkar JM, Fries BC. Candidal infections of the genitourinary tract. Clin Microbiol Rev. 2010;23:253–73.
Article
PubMed
PubMed Central
Google Scholar
Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJS. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62:10–24.
Article
CAS
PubMed
Google Scholar
Gullo A. Invasive fungal infections: the challenge continues. Drugs. 2009;69(Suppl 1):65–73.
Article
PubMed
Google Scholar
Yang YL, Cheng HH, Ho YA, Hsiao CF, Lo HJ. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect. 2003;36:187–91.
CAS
PubMed
Google Scholar
Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV, Keniya MV, Tanabe K, Niimi M, Goffeau A, Monk BC. Efflux mediated antifungal drug resistance. Clin Microbiol Rev. 2009;22:291–321.
Article
CAS
PubMed
PubMed Central
Google Scholar
White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev. 1998;11:382–402.
CAS
PubMed
PubMed Central
Google Scholar
Hospenthal DR, Beckius ML, Floyd KL, Horvath LL, Murray CK. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida. Ann Clin Microbiol Antimicrob. 2006;5:1.
Article
PubMed
PubMed Central
Google Scholar
Isenberg HD. Mycology and Antifungal Susceptibility Testing. In: Gracia LS, Isenberg HD, editors. Clinical microbiology procedure handbook, vol. 2. 2nd ed. Washington, DC: ASM Press; 2004. p. 8.0.1–8.10.7.
Google Scholar
Kauffman C, Fisher J. Candida urinary tract infections: diagnosis. Clin Infect Dis. 2011;52(suppl 6):S452–6.
Article
PubMed
Google Scholar
Yucesoy M, Esen N, Yulung N. Use of chromogenic agar for the identification of Candida albicans strains. Kobe J Med Sci. 2001;47:161–7.
CAS
PubMed
Google Scholar
Murray CK, Beckius ML, Green JA, Hospenthal DR. Use of chromogenic medium for the isolation of yeasts from clinical specimens. J Med Microbiol. 2005;54:981–5.
Article
CAS
PubMed
Google Scholar
CLS Institute. Method for antifungal disk diffusion susceptibility testing of yeasts: approved standard M44-A. Clinical and Laboratory Standards Institute: Wayne; 2006 (Material and Method).
Google Scholar
Lee SC, Fung CP, Lee N, See LC, Huang JS, Tsai CJ, Chen KS, Shieh WB. Fluconazole disk diffusion test with methylene blue- and glucose-enriched Mueller–Hinton agar for determining susceptibility of Candida species. J Clin Microbiol. 2001;39:1615–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pfaller MA, Boyken L, Messer SA, Hollis RJ, Diekema DJ. Stability of Mueller–Hinton agar supplemented with glucose and methylene blue for disk diffusion testing of fluconazole and voriconazole. J Clin Microbiol. 2004;42:1288–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
ElFeky DS, Gohar NM, El-Seidi EA, Ezzat MM, AboElew SH. Species identification and antifungal susceptibility pattern of Candida isolates in cases of vulvovaginal candidiasis. Alex Med J. 2016;52:269–77.
Article
Google Scholar
Manikandan C, Amsath A. Characterization and susceptibility pattern of Candida species isolated from urine sample in pattukkottai, Tamilnadu, India. Int J Pure Appl Zool. 2015;3:17–23.
Google Scholar
Mondal S, Mondal A, Pal N, Banerjee P, Kumar S, Bhargava D. Species distribution and in vitro antifungal susceptibility patterns of Candida. J Inst Med. 2013;35:45–9.
Article
Google Scholar
Sajjan AC, Mahalakshmi VV, Hajare V. Prevalence and antifungal susceptibility of Candida species isolated from patients attending tertiary care hospital. IOSR J Dent Med Sci. 2014;13:44–9.
Article
Google Scholar
Jayalakshmi L, RatnaKumari G, Samson SH. Isolation, speciation and antifungal susceptibility testing of candida from clinical specimens at a tertiary care hospital. Sch J App Med Sci. 2014;2:3193–8.
Google Scholar
Swoboda-Kopec E, Kawecki D, Wroblewska M, Krawczyk M, Luczak M. Epidemiology and susceptibility to antifungal agents of fungi isolated from clinical specimens from patients hospitalized in the Department of General and Liver Surgery of the Medical University of Warsaw. Transplant Proc. 2003;35:2298–303.
Article
CAS
PubMed
Google Scholar
Kiraz N, Oz Y. Species distribution and in vitro antifungal susceptibility of clinical Candida isolates from a university hospital in Turkey over a 5-year period. Med Mycol. 2011;49:126–31.
Article
PubMed
Google Scholar
Fleck R, Dietz A, Hof H. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. J Antimicrob Chemother. 2007;59:767–71.
Article
CAS
PubMed
Google Scholar
Chakraborti A, Ghosh A, Batra R, Kaushal A, Roy P, Singh H. Antifungal susceptibility patterns of the non-C. albicans species and the distribution of the species which were isolated from Candidaemia cases over a 5 year period. Indian J Med Res. 1996;104:171–6.
Google Scholar
Mokaddas EM, Al-Sweih NA, Khan ZU. The species distribution and the antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10 year study. J Med Microbiol. 2007;56:255–9.
Article
CAS
PubMed
Google Scholar
Nadeem SG, Hakim ST, Kazmi SU. Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited setting. Libyan J Med. 2010;5:1–6.
Article
Google Scholar
Jha BJ, Dey S, Tamang MD, Joshy ME, Shivananda PG, Brahmadatan KN. Characterization of Candida species isolated from cases of lower respiratory tract infection. Kathmandu Univ Med J. 2006;4:290–4.
CAS
Google Scholar
Al-mamari A, Al-buryhi M, Al-heggami MA, Al-hag S. Identify and sensitivity to antifungal drugs of Candida species causing vaginitis isolated from vulvovaginal infected patients in Sana’a city. Der Pharm Chem. 2014;6:336–42.
Google Scholar
Hamza OJ, Matee MI, Moshi MJ, Simon EN, Mugusi F. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiol. 2008;8:135.
Article
PubMed
PubMed Central
Google Scholar
Mulu A, Kassu A, Anagaw B, Moges B, Gelaw A, Alemayehu M, Belyhun Y, Biadglegne F, Hurissa Z, Moges F, Isogai E. Frequent detection of ‘azole’ resistant Candida species among late presenting AIDS patients in northwest Ethiopia. BMC Infect Dis. 2013;13:82.
Article
PubMed
PubMed Central
Google Scholar
Binesh LY, Kalyani M. Phenotypic characterization of Candida species and their antifungal susceptibility from a tertiary care centre. JPBMS. 2011;11:12.
Google Scholar
Zomorodian K, Rahimi MJ, Pakshir K, Motamedi M, Ghiasi MR, Rezashah H. Determination of antifungal susceptibility patterns among the clinical isolates of Candida species. J Glob Infect Dis. 2011;3:357–60.
Article
PubMed
PubMed Central
Google Scholar